Archive | Melanoma In The News

Dr. Ascierto on Triplet of Encorafenib, Binimetinib, and Ribociclib in Melanoma

Source: OncLive, June 2017 Paolo A. Ascierto, MD, director at the Unit of Melanoma, Cancer Immunotherapy and Innovative Therapy, National Tumor Institute Fondazione G. Pascale, discusses findings from a phase Ib/II dose-escalation study evaluating triple combination therapy with encorafenib, binimetinib, and ribociclib (Kisqali) in patients with BRAF V600-mutant solid tumors and melanoma. This is the […]

Read the full story

Posted in Melanoma In The News, Clinical Trials

More Immuno Rx Strategies for Advanced Melanoma

Washington—Combining checkpoint inhibitors yields an overall survival (OS) benefit in advanced melanoma, according to Phase III data presented at the 2017 annual meeting of the American Association for Cancer Research (AACR).

Read the full story

Posted in Melanoma In The News, Other Melanoma Research

Cellular sweet spot found in skin-cancer battle

A team of researchers has pinpointed a sugar modification in cells that spurs the spread of skin cancer. Its findings, which appear in the latest issue of the journal Cancer Cell, spotlight a target in the battle against melanoma.

Read the full story

Posted in Melanoma In The News, Other Melanoma Research

VIDEO: Immune therapy effective, durable in treatment-naive melanoma brain metastases

CHICAGO – Immune therapy shows promise for use in the treatment of melanoma brain metastases, especially for treatment-naive patients, judging from the findings of a new phase II randomized study.

Read the full story

Posted in Melanoma In The News, OncLive Videos

Melanoma Google Alerts

Melanoma Google Alerts is a summary of daily articles found in print and on the internet. The articles do not necessarily represent the views of Melbourne Melanoma Project

News Archives

News Categories